EN PL

RAPS: FDA Finalizes Lot Distribution Report Guidance With Few Changes

30.04.2015
New guidance issued by the US Food and Drug Administration (FDA) is intended to clarify how biopharmaceutical companies should submit so-called \"lot distribution reports\" (LDRs)—reports detailing the quantity of a product which has been legally distributed.